The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...
Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...
The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...
Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation ...
allAfrica.com on MSN
Biovac opens new product development laboratory in Cape Town
The Deputy Minister of Science, Technology and Innovation, Dr Nomalungelo Gina, will deliver the keynote address at the opening of Biovac’s new product development laboratory in Cape Town on Thursday, ...
Stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells can force tumors to ...
Bizcommunity on MSN
Aspen Pharmacare reaches €25m settlement in mRNA contract dispute
Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today announced that it will report ...
A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback